HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer

NCT02165605 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: HylaCare
DRUG: Placebo

Sponsor

University of Texas Southwestern Medical Center